Serum antimüllerian hormone concentration increases with ovarian endometrioma size.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
05 2019
Historique:
received: 24 07 2018
revised: 09 01 2019
accepted: 09 01 2019
pubmed: 18 3 2019
medline: 4 9 2019
entrez: 18 3 2019
Statut: ppublish

Résumé

To examine whether serum antimüllerian hormone (AMH) levels correlate with the size of ovarian endometrioma (OMA). An observational cross-sectional study. University hospital. Two hundred and sixty-seven nonpregnant women, aged 18-42 years, with no prior history of surgery for endometriosis and a histologically documented ovarian cyst. Surgical management for a benign ovarian cyst. Correlation between serum AMH concentration and cyst size according to OMA and non-OMA benign cyst. Women with OMA were compared with a control group of women who had non-OMA benign ovarian cysts. The AMH assay samples were collected less than a month before the surgery. Between January 2004 and September 2016, 148 women were allocated to the OMA group and 119 to the non-OMA benign cyst group. The AMH concentrations were not statistically significantly different between the two groups (3.7 ± 2.8 ng/mL vs. 4.1 ± 3.3 ng/mL). A multiple linear regression model accounting for potential confounders revealed that the log10 of the serum AMH concentration positively correlated with the log10 of the OMA cyst volume (R In women no prior history of surgery for endometriosis, serum AMH levels increased with cyst size in cases of OMA.

Identifiants

pubmed: 30878253
pii: S0015-0282(19)30051-2
doi: 10.1016/j.fertnstert.2019.01.013
pii:
doi:

Substances chimiques

Biomarkers 0
Anti-Mullerian Hormone 80497-65-0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

944-952.e1

Informations de copyright

Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Louis Marcellin (L)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Développent, Reproduction et Cancer", INSERM U1016, Institut Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Stress Oxydant, Prolifération Cellulaire et Inflammation", Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Electronic address: louis.marcellin@aphp.fr.

Pietro Santulli (P)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Développent, Reproduction et Cancer", INSERM U1016, Institut Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Stress Oxydant, Prolifération Cellulaire et Inflammation", Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Mathilde Bourdon (M)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Stress Oxydant, Prolifération Cellulaire et Inflammation", Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Clémence Comte (C)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Chloé Maignien (C)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Stress Oxydant, Prolifération Cellulaire et Inflammation", Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Pierre Alexandre Just (PA)

Service de Pathologie, CAncer Research for PErsonalized Medicine (CARPEM), Faculté de Médecine, Hôpitaux Universitaires Paris Centre (AP-HP), Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Isabelle Streuli (I)

Unité de Médecine de la Reproduction et d'Endocrinologie Gynécologique, Hôpitaux Universitaires de Genève et Faculté de Médecine, Université de Genève, Geneva, Switzerland.

Bruno Borghese (B)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Développent, Reproduction et Cancer", INSERM U1016, Institut Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Charles Chapron (C)

Département de Gynécologie Obsétrique II et Médecine de la Reproduction, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Développent, Reproduction et Cancer", INSERM U1016, Institut Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Département "Stress Oxydant, Prolifération Cellulaire et Inflammation", Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH